KNKengo Nakahara

Kengo Nakahara

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kengo Nakahara has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • Nobumasa Takasugi

    Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan

    7 shared publications
  • Takashi Uehara

    Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan

    7 shared publications
  • Kana Fujikawa

    Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan

    3 shared publications
  • Akihiro Ito

    School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0355, Japan

    2 shared publications
  • Hideki Hiraoka

    Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University

    2 shared publications
  • Kosaku Okuda

    Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan

    2 shared publications

Latest Publications

  • Open Access

    Pivotal role for S-nitrosylation of DNA methyltransferase 3B in epigenetic regulation of tumorigenesis

    by Kosaku Okuda, Kengo Nakahara, Akihiro Ito, Yuta Iijima, Ryosuke Nomura, Ashutosh Kumar, Kana Fujikawa, Kazuya Adachi, Yuki Shimada, Satoshi Fujio, et al.

    DNA methyltransferases (DNMTs) catalyze methylation at the C5 position of cytosine withS-adenosyl-l-methionine. Methylation regulates gene expression, serving a variety of physiological and pathophysiological roles. The chemical mechanisms regulating DNMT enzymatic activity, however, are not fully elucidated. Here, we show that protein S-nitrosylation of a cysteine residue in DNMT3B attenuates DNMT3B enzymatic activity and consequent aberrant upregulation of gene expression. These genes include Cyclin D2 (Ccnd2), which is required for neoplastic cell proliferation in some tumor types. In cell-based and in vivo cancer models, only DNMT3B enzymatic activity, and not DNMT1 or DNMT3A, affectsCcnd2expression. Using structure-based virtual screening, we discovered chemical compounds that specifically inhibitS-nitrosylation without directly affecting DNMT3B enzymatic activity. The lead compound, designated DBIC, inhibitsS-nitrosylation of DNMT3B at low concentrations (IC50 ≤ 100 nM). Treatment with DBIC prevents nitric oxide (NO)-induced conversion of human colonic adenoma to adenocarcinoma in vitro. Additionally, in vivo treatment with DBIC strongly attenuates tumor development in a mouse model of carcinogenesis triggered by inflammation-induced generation of NO. Our results demonstrate that de novo DNA methylation mediated by DNMT3B is regulated by NO, and DBIC protects against tumor formation by preventing aberrantS-nitrosylation of DNMT3B.


  • Open Access

    Regulation of Gene Expression via Protein Oxidation

    by Yuta Iijima, Tohta Mizushima, Kengo Nakahara, Nobumasa Takasugi, Yosuke Matsushita, Toyomasa Katagiri, Takashi Uehara

    Epigenetic dysregulation, such as aberrant DNA methylation, is one of the hallmarks of cancer cells, however the mechanisms by which these dysregulations occur remain unclear. Previously, we found that DNA methyltransferase 3B (DNMT3B), which catalyzes cytosine methylation, is selectively oxidized by several stresses. A cysteine residue is the modification site on DNMT3B. As oxidation of DNMT3B attenuates its enzymatic activity, this reaction may be related to the epigenetic regulation. In this study, we focused on the cell cycle regulator CCND2 and examined whether its expression is regulated by oxidative stress and enzymatic activity of DNMT3B. Indeed, exposure to the stress and the universal DNMT inhibitor 5-aza-2'-deoxycytidine induced CCND2 expression. When DNMT1, DNMT3A, and DNMT3B were overexpressed, only DNMT3B significantly reduced CCND2 mRNA levels. CS mutant, which lost enzymatic activity, had no effect on CCND2 mRNA levels compared with the wild type. The siRNA knockdown of DNMT3B markedly enhanced CCND2 mRNA levels. Our data strongly suggest DNMT3B-specific regulation of CCND2 expression. Finally, bisulfite sequencing analysis revealed that oxidative stress significantly decreased DNA methylation levels in the CCND2 promoter region. These results indicate that oxidation of DNMT3B plays an important role in epigenetic regulation and may lead us to know the mechanism of epigenetic dysregulation in cancer cells.

  • Open Access

    Covalent N-arylation by the pollutant 1,2-naphthoquinone activates the EGF receptor

    by Kengo Nakahara, Kyohei Hamada, Tomoki Tsuchida, Nobumasa Takasugi, Yumi Abiko, Kazuhiko Shien, Shinichi Toyooka, Yoshito Kumagai, Takashi Uehara


  • Open Access

    Attenuation of Macrophage Migration Inhibitory Factor-Stimulated Signaling via S-Nitrosylation

    by Kengo Nakahara, Kana Fujikawa, Hideki Hiraoka, Ikuko Miyazaki, Masato Asanuma, Akihiro Ito, Nobumasa Takasugi, Takashi Uehara

    Nitric oxide (NO) is a key signaling molecule that has various effects via S-nitrosylation, a reversible post-translational modification that affects the enzymatic activity, localization, and metabolism of target proteins. As chronic nitrosative stress correlates with neurodegeneration, the targets have received focused attention. Macrophage migration inhibitory factor (MIF) plays a pivotal role in the induction of gene expression to control inflammatory responses. MIF acts as a ligand for CD74 receptor and activates the Src-p38 mitogen-activated protein kinase (MAPK) cascade. MIF also elevates the expression of brain-derived neurotrophic factor (BDNF), which contributes to the viability of neurons. Here, we show that MIF is S-nitrosylated by a physiological NO donor. Interestingly, the induction of S-nitrosylation resulted in a loss of MIF activity following stimulation of the Src and p38 MAPK signaling pathways and the induction of BDNF expression. Our results shed light on the pathogenic mechanisms of neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease.


  • Open Access

    The Emerging Role of Electrophiles as a Key Regulator for Endoplasmic Reticulum (ER) Stress

    by Nobumasa Takasugi, Hideki Hiraoka, Kengo Nakahara, Shiori Akiyama, Kana Fujikawa, Ryosuke Nomura, Moeka Furuichi, Takashi Uehara

    The unfolded protein response (UPR) is activated by the accumulation of misfolded proteins in the endoplasmic reticulum (ER), which is called ER stress. ER stress sensors PERK, IRE1, and ATF6 play a central role in the initiation and regulation of the UPR; they inhibit novel protein synthesis and upregulate ER chaperones, such as protein disulfide isomerase, to remove unfolded proteins. However, when recovery from ER stress is difficult, the UPR pathway is activated to eliminate unhealthy cells. This signaling transition is the key event of many human diseases. However, the precise mechanisms are largely unknown. Intriguingly, reactive electrophilic species (RES), which exist in the environment or are produced through cellular metabolism, have been identified as a key player of this transition. In this review, we focused on the function of representative RES: nitric oxide (NO) as a gaseous RES, 4-hydroxynonenal (HNE) as a lipid RES, and methylmercury (MeHg) as an environmental organic compound RES, to outline the relationship between ER stress and RES. Modulation by RES might be a target for the development of next-generation therapy for ER stress-associated diseases.


  • Open Access

    Modulation of Unfolded Protein Response by Methylmercury

    by Hideki Hiraoka, Kengo Nakahara, Yuki Kaneko, Shiori Akiyama, Kosaku Okuda, Takao Iwawaki, Masatake Fujimura, Yoshito Kumagai, Nobumasa Takasugi, Takashi Uehara

    Methylmercury (MeHg) results in cell death through endoplasmic reticulum (ER) stress. Previously, we reported that MeHg induces S-mercuration at cysteine 383 or 386 in protein disulfide isomerase (PDI), and this modification induces the loss of enzymatic activity. Because PDI is a key enzyme for the maturation of nascent protein harboring a disulfide bond, the disruption in PDI function by MeHg results in ER stress via the accumulation of misfolded proteins. However, the effects of MeHg on unfolded protein response (UPR) sensors and their signaling remain unclear. In the present study, we show that UPR is regulated by MeHg. We found that MeHg specifically attenuated inositol-requiring enzyme 1α (IRE1α)–x-box binding protein 1 (XBP1) branch, but not the protein kinase RNA-like endoplasmic reticulum kinase (PERK) and activating transcriptional factor 6 (ATF6) branches. Treatment with GSK2606414, a specific PERK inhibitor, significantly inhibited MeHg-induced cell death. These findings suggest that MeHg exquisitely regulates UPR signaling involved in cell death.